Bacteroides fragilis was isolated from appendix abscess. It is an anaerobic, Gram-negative, pleomorphic to rod-shaped bacterium.
For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.
CAT | Size | Price | Quantity | |
---|---|---|---|---|
LBST-013FG |
|
Product Information | |
---|---|
Product Overview | Bacteroides fragilis was isolated from appendix abscess. It is an anaerobic, Gram-negative, pleomorphic to rod-shaped bacterium. |
Target | Bacteroides |
Genus | Bacteroides |
Strain Designation | VPI 2553 |
Application | Media testing; Quality control strain; Susceptibility testing; Quality control strain for BBL and MicroScan. |
Culture Medium | Columbia blood agar |
Culture Conditions | 37°C; Anaerobic |
Source | Appendix abscess |
Risk Group | 2 |
Product Format | Freeze-dried |
Packaging | Ampoule tube |
Storage | -80°C |
Shelf Life | 6 years |
Target Introduction | |
---|---|
Introduction | Bacteroides is a group of promising candidates that has attracted major attentions from scientists as model organisms or community for the investigations of the intestinal microbiota field, due to their powerful adaption characteristics in the host and especially the underlying benefits. Bacteroides is a genus of Gram-negative, obligate anaerobic bacteria. Bacteroides species are non endospore-forming bacilli, and may be either motile or nonmotile, depending on the species. Bacteroides; order is the most abundant group of Gram-negative bacteria which flourish in the human intestine at high densities of 109-1011 CFU per gram of feces, and constitutes over 30 species which are more closely related than members in other bacteria orders. And, Bacteroides is considered as one of the major genera of the core microbiota module, of which species with relative abundance of over 1% refers to B. uniformis, B. vulgatus, B. caccae, and B. thetaiotaomicron. In addition to the unique physiological characteristics and the special ecological dynamics, Bacteroides species are under investigations for their underlying beneficial dialogues with the host. Bacteroides species to be considered as next-generation probiotics, and the application of which in prevention or intervention in dysbiosis of gut microbiota and the associated disorders requires further investigations in the modulatory mechanisms and safety evaluation. Bacteroides is one of the dominant contributors of SCFA among the intestinal commensals, mostly in the form of acetate and propionate. Accumulated acetate blocks the transportation of toxins between gut lumen and blood, while propionate is capable of inducing the apoptosis of human colon carcinoma cells, and thus avoids the formation of tumors. Moreover, Vitamin K, which is mainly synthesized by gut microbiota candidates such as Bacteroides, can help prevent or treat osteoporosis by increasing bone mineral density. |
Alternative Names | Bacteroides fragilis |
Bacteroides fragilis; requires strict anaerobic handling procedures to maintain viability. Utilize anaerobic chambers or jars with gas packs, and ensure minimal exposure to oxygen during transfers and culturing.
Bacteroides fragilis; thrives in media such as BHI (Brain Heart Infusion) broth supplemented with hemin and vitamin K. This supports its growth requirements and ensures optimal cell density for experiments.
To revive Bacteroides fragilis; , quickly thaw the frozen vial at 37°C, then immediately inoculate into pre-reduced anaerobic media. Incubate under anaerobic conditions to achieve maximum recovery and viability.
Purity of Bacteroides fragilis; can be assessed by streaking onto selective agar plates and checking for uniform colony morphology. PCR-based methods targeting specific genetic markers can also verify strain purity.
For long-term storage, Bacteroides fragilis; should be cryopreserved in glycerol stocks at -80°C. It is crucial to aliquot stocks into small volumes to prevent multiple freeze-thaw cycles, which can reduce viability.
Bacteroides fragilis; VPI 2553 requires strict anaerobic handling procedures to maintain viability. Utilize anaerobic chambers or jars with gas packs, and ensure minimal exposure to oxygen during transfers and culturing.
Bacteroides fragilis; VPI 2553 thrives in media such as BHI (Brain Heart Infusion) broth supplemented with hemin and vitamin K. This supports its growth requirements and ensures optimal cell density for experiments.
To revive Bacteroides fragilis; VPI 2553, quickly thaw the frozen vial at 37°C, then immediately inoculate into pre-reduced anaerobic media. Incubate under anaerobic conditions to achieve maximum recovery and viability.
Purity of Bacteroides fragilis; VPI 2553 can be assessed by streaking onto selective agar plates and checking for uniform colony morphology. PCR-based methods targeting specific genetic markers can also verify strain purity.
For long-term storage, Bacteroides fragilis; VPI 2553 should be cryopreserved in glycerol stocks at -80°C. It is crucial to aliquot stocks into small volumes to prevent multiple freeze-thaw cycles, which can reduce viability.
Click the button below to contact us or submit your feedback about this product.
For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.
Copyright © 2024 Creative Biolabs. All Rights Reserved.